Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04300140
Title Efficacy and Safety Study of AVB-S6-500 in Patients With Clear Cell Renal Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Aravive, Inc.
Indications

clear cell renal cell carcinoma

Therapies

AVB-S6-500 + Cabozantinib

Cabozantinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.